To determine whether sulfonylureas and exogenous insulin have different effects on insulin action, we studied eight patients with non-insulin-dependent diabetes mellitus before and after three months of treatment with tolazamide and exogenous semisynthetic human insulin, using a randomized crossover design. Therapy with tolazamide and therapy with insulin resulted in similar improvement of glycemic control, as measured by a decrease in mean glycosylated hemoglobin (+/- SEM) from 9.4 +/- 0.7 percent to 7.7 +/- 0.5 percent with tolazamide and to 7.1 +/- 0.2 percent with exogenous insulin (P less than 0.01 for both comparisons). Therapy with either tolazamide or exogenous insulin resulted in a similar lowering (P less than 0.05) of postabsorptive glucose-production rates (from 2.3 +/- 0.1 to 2.0 +/- 0.2 and 1.8 +/- 0.1 mg per kilogram of body weight per minute, respectively) but not to normal (1.5 +/- 0.1 mg per kilogram per minute). Both tolazamide and exogenous insulin increased (P less than 0.05) glucose utilization at supraphysiologic insulin concentrations (from 6.2 +/- 0.7 to 7.7 +/- 0.6 mg per kilogram per minute with tolazamide and to 7.8 +/- 0.6 mg per kilogram per minute with exogenous insulin) to nondiabetic rates (7.9 +/- 0.5 mg per kilogram per minute). Neither agent altered erythrocyte insulin binding at physiologic insulin concentrations. We conclude that treatment with sulfonylureas or exogenous insulin results in equivalent improvement in insulin action in patients with non-insulin-dependent diabetes mellitus. Therefore, the choice between these agents should be based on considerations other than their ability to ameliorate insulin resistance.
This article has been cited by other articles:
Basu, R., Shah, P., Basu, A., Norby, B., Dicke, B., Chandramouli, V., Cohen, O., Landau, B. R., Rizza, R. A.
(2008). Comparison of the Effects of Pioglitazone and Metformin on Hepatic and Extra-Hepatic Insulin Action in People With Type 2 Diabetes. Diabetes
57: 24-31
[Abstract][Full Text]
Juurinen, L., Tiikkainen, M., Hakkinen, A.-M., Hakkarainen, A., Yki-Jarvinen, H.
(2007). Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes. Am. J. Physiol. Endocrinol. Metab.
292: E829-E835
[Abstract][Full Text]
Shadid, S., Stehouwer, C. D. A., Jensen, M. D.
(2006). Diet/Exercise Versus Pioglitazone: Effects of Insulin Sensitization with Decreasing or Increasing Fat Mass on Adipokines and Inflammatory Markers. J. Clin. Endocrinol. Metab.
91: 3418-3425
[Abstract][Full Text]
Woerle, H. J., Szoke, E., Meyer, C., Dostou, J. M., Wittlin, S. D., Gosmanov, N. R., Welle, S. L., Gerich, J. E.
(2006). Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes. Am. J. Physiol. Endocrinol. Metab.
290: E67-E77
[Abstract][Full Text]
Basu, R., Chandramouli, V., Dicke, B., Landau, B., Rizza, R.
(2005). Obesity and Type 2 Diabetes Impair Insulin-Induced Suppression of Glycogenolysis as Well as Gluconeogenesis. Diabetes
54: 1942-1948
[Abstract][Full Text]
Basu, R., Basu, A., Johnson, C. M., Schwenk, W. F., Rizza, R. A.
(2004). Insulin Dose-Response Curves for Stimulation of Splanchnic Glucose Uptake and Suppression of Endogenous Glucose Production Differ in Nondiabetic Humans and Are Abnormal in People With Type 2 Diabetes. Diabetes
53: 2042-2050
[Abstract][Full Text]
Basu, R., Schwenk, W. F., Rizza, R. A.
(2004). Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes. Am. J. Physiol. Endocrinol. Metab.
287: E55-E62
[Abstract][Full Text]
Hunter, S. J., Boyd, A. C., O'Harte, F. P.M., McKillop, A. M., Wiggam, M. I., Mooney, M. H., McCluskey, J. T., Lindsay, J. R., Ennis, C. N., Gamble, R., Sheridan, B., Barnett, C. R., McNulty, H., Bell, P. M., Flatt, P. R.
(2003). Demonstration of Glycated Insulin in Human Diabetic Plasma and Decreased Biological Activity Assessed by Euglycemic-Hyperinsulinemic Clamp Technique in Humans. Diabetes
52: 492-498
[Abstract][Full Text]
(2003). Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care
26: s5-20
[Full Text]
Kumar, N., Dey, C. S.
(2002). Gliclazide increases insulin receptor tyrosine phosphorylation but not p38 phosphorylation in insulin-resistant skeletal muscle cells. J. Exp. Biol.
205: 3739-3746
[Abstract][Full Text]
Strowig, S. M., Aviles-Santa, M. L., Raskin, P.
(2002). Comparison of Insulin Monotherapy and Combination Therapy With Insulin and Metformin or Insulin and Troglitazone in Type 2 Diabetes. Diabetes Care
25: 1691-1698
[Abstract][Full Text]
Anderwald, C., Bernroider, E., Krssak, M., Stingl, H., Brehm, A., Bischof, M. G., Nowotny, P., Roden, M., Waldhausl, W.
(2002). Effects of Insulin Treatment in Type 2 Diabetic Patients on Intracellular Lipid Content in Liver and Skeletal Muscle. Diabetes
51: 3025-3032
[Abstract][Full Text]
Pratipanawatr, T., Cusi, K., Ngo, P., Pratipanawatr, W., Mandarino, L. J., DeFronzo, R. A.
(2002). Normalization of Plasma Glucose Concentration by Insulin Therapy Improves Insulin-Stimulated Glycogen Synthesis in Type 2 Diabetes. Diabetes
51: 462-468
[Abstract][Full Text]
Matthaei, S., Stumvoll, M., Kellerer, M., Häring, H.-U.
(2000). Pathophysiology and Pharmacological Treatment of Insulin Resistance. Endocr. Rev.
21: 585-618
[Abstract][Full Text]
Basu, R., Basu, A., Nielsen, M., Shah, P., Rizza, R. A.
(1999). Effect of Overnight Restoration of Euglycemia on Glucose Effectiveness in Type 2 Diabetes Mellitus. J. Clin. Endocrinol. Metab.
84: 2314-2319
[Abstract][Full Text]
Wise, S. D., Nielsen, M. F., Cryer, P. E., Rizza, R. A.
(1998). Overnight Normalization of Glucose Concentrations Improves Hepatic But Not Extrahepatic Insulin Action in Subjects with Type 2 Diabetes Mellitus. J. Clin. Endocrinol. Metab.
83: 2461-2469
[Abstract][Full Text]
Colwell, J. A.
(1996). The Feasibility of Intensive Insulin Management in Non-Insulin-dependent Diabetes Mellitus: Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM. ANN INTERN MED
124: 131-135
[Abstract][Full Text]
Nathan, D. M.
(1993). Long-Term Complications of Diabetes Mellitus. NEJM
328: 1676-1685
[Full Text]
Previous
